Log in | Register

E-mail
Company Name

Actor Florence Henderson Discusses Eye Surgery and Crystalens®

Loading...
MONDAY, JUNE 21, 2010

LOS ANGELES – Bausch + Lomb, the global eye health company, today announced its partnership with actress Florence Henderson to inform older Americans about cataracts which are the leading cause of diminishing vision. It is estimated that 20.5 million Americans over the age of 40 have cataracts, a clouding of the eye's natural lens impairing one's ability to see clearly.

Henderson, the well-known Broadway, film and TV actress, was treated with the Crystalens® which is the only FDA-approved accommodating intraocular lens (IOL). She will share her experiences in order to generate a larger conversation among consumers about the symptoms, diagnosis and various correction techniques for cataract patients. Ms. Henderson has enjoyed a storied entertainment career that has spanned five decades. She is best known for her role as Carol Brady in the iconic television series The Brady Bunch, which ran on network television from 1969 to 1974 and continues in syndication today.

"When my doctor told me what I could expect after the Crystalens surgery, I said, 'Wow, sign me
up,' " said Henderson. "I didn't realize what I had been missing before I had my Crystalens surgery. The colors of everything are so much brighter and the improved sharpness and clarity of my vision are very noticeable," said Ms. Henderson.

Cataracts can begin to develop as early one's mid-40s. While 91 percent of cataracts are caused by the inevitable aging process, they can easily be corrected. In fact, cataract surgery is one of the safest and most common surgeries in the United States. Henderson, after consulting with her doctor and determining she was a qualified candidate, opted for the Crystalens procedure.

"Florence Henderson is obviously a very active woman. There are many vision correction options for the patient who is over 50 years old.  When I examined Florence, I realized she was a candidate for the Crystalens. We discussed how it would help her vision up close, far away and everything in between. She's doing very well since her surgery," said Dr. James Khodabakhsh of the Beverly Hills Vision Institute in Beverly Hills, Calif.

Unlike a standard lens, the Crystalens treats the cataract while simultaneously correcting a patient’s full range of vision, thus reducing or eliminating the dependence on glasses.

“If something works for me like Crystalens has, I like to share my experience. I am happy to tell the story to empower, inspire and motivate people to take care of themselves. As with any health condition, it’s best to gather information, know the facts and discuss them with your doctor," said Henderson.

Ms. Henderson, who shared her experiences recently with surgeons attending the American Society of Cataract and Refractive Surgery in Boston, is currently conducting a series of interviews with media outlets around the country. She is talking about her surgery, its results and reminding people about the importance of regular eye exams and how important it is to talk with your doctor about picking the right treatment for each person.

For more information about Florence Henderson, cataracts and treatment options, including the Crystalens, please visit www.crystalens.com

SOURCE

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Importance of Fundamentals

The Importance of Fundamentals

Aug 31 | Girish Malhotra, PE, President, EPCOT International

Globally, Johnson & Johnson is known for its integrity and product quality. A few years ago they handled the Tylenol situation extremely well and were commended for it. It is astounding that the year 2010 has become a nightmare for them.  

The Quality Control Unit: Invertebrates Need Not Apply

The Quality Control Unit: Invertebrates Need Not Apply

Aug 30 | The QA Pharm

The Quality Control Unit (QCU) is the only pharmaceutical function that has a job description codified in the CGMP regulations. Don’t you find this remarkable? In fact, an entire section is devoted to describing the responsibility of the QCU and how it is to operate within the organization—namely independently.        

Multimedia

Timothy Cote - Office of Orphan Products Development

Aug 13 | Root

From approving medicines to treating snake bites to Cystic Fibrosis - Dr. Tim Cote describes a special office at the FDA, designed to address needs of people with rare diseases. Timothy Cote, M.D. - Director, Office of Orphan Products Development

Charles River Labs On WuXi PharmaTech Acquisition

Charles River Labs On WuXi PharmaTech Acquisition

May 25 | Video

Charles Rivers Laboratories International Chief Officer talks about the recent WuXi PharmaTech acquisition

Biogen Idec - 2010 Facility of the Year Award Winner - Operational Excellence

Biogen Idec - 2010 Facility of the Year Award Winner - Operational Excellence

Apr 27 | Video

Peter Flinn, Biogen Idec's Senior Director, Global Project Engineering talks to Pharmaceutical Processing's Editor-In-Chief Mike Auerbach about the company's Large-Scale Manufacturing Technology Map Project in Research Triangle Park, North Carolina. The project won the 2010 Operational...

MannKind Corporation - 2010 Facility of the Year Award Winner - Equipment & Process Innovation

MannKind Corporation - 2010 Facility of the Year Award Winner - Equipment & Process Innovation

Apr 28 | Video

Juergen Martens, Ph,D. MannKind Corporation's Corporate Vice President and Chief Technical Officer talks to Pharmaceutical Processing's Editor-In-Chief Mike Auerbach durng INTERPHEX2010 about the company's Technosphere Insulin Manufacturing Facility located in Danbury, Connecticut. The...